---
layout: post
title: June 2010 proposed INNs for protein kinase inhibitors
date: '2010-06-23T12:32:00.007+01:00'
author: John Overington
tags:
- INNS and USANS
- Kinase inhibitor
modified_time: '2010-12-23T10:02:33.485Z'
thumbnail: http://1.bp.blogspot.com/_SlPG9DIz_AA/TRMeLiJkIFI/AAAAAAAAA90/yl_6qgi2C6c/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-4616387352825601372
blogger_orig_url: http://chembl.blogspot.com/2010/06/june-2010-proposed-inns-for-protein.html
---

<div class="separator" style="clear: both; text-align: center;"><a href="http://1.bp.blogspot.com/_SlPG9DIz_AA/TRMeLiJkIFI/AAAAAAAAA90/yl_6qgi2C6c/s1600/inns+and+usans.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://1.bp.blogspot.com/_SlPG9DIz_AA/TRMeLiJkIFI/AAAAAAAAA90/yl_6qgi2C6c/s1600/inns+and+usans.png" /></a></div><div class="separator" style="clear: both; text-align: center;"><br />
</div>There is a new clutch of proposed protein kinase inhibitor INNs. These are:<br />
<br />
<b>Amuvatinib</b>&nbsp;aka MP-470 and HPK-46, SuperGen's FLT3 inhibitor <br />
<pre>S=C(NCc2ccc1OCOc1c2)N6CCN(c4ncnc5c3ccccc3oc45)CC6</pre><br />
<div class="separator" style="clear: both; text-align: center;"><a href="http://2.bp.blogspot.com/_SlPG9DIz_AA/TCHvwXKBH-I/AAAAAAAAAx8/tJZ3Sk3FXx4/s1600/Amuvatinib1.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://2.bp.blogspot.com/_SlPG9DIz_AA/TCHvwXKBH-I/AAAAAAAAAx8/tJZ3Sk3FXx4/s320/Amuvatinib1.png" /></a></div><div class="separator" style="clear: both; text-align: center;"><br />
</div><b>Crizotinib</b>&nbsp;aka PF-2,341,066, Pfizer's ALK and MET inhibitor <br />
<pre>C[C@@H](Oc3cc(c2cnn(C1CCNCC1)c2)cnc3N)c4c(Cl)ccc(F)c4Cl</pre><br />
<div class="separator" style="clear: both; text-align: center;"><a href="http://3.bp.blogspot.com/_SlPG9DIz_AA/TCHv24RMpRI/AAAAAAAAAyE/3vssOM3cDY8/s1600/Crizotinib1.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://3.bp.blogspot.com/_SlPG9DIz_AA/TCHv24RMpRI/AAAAAAAAAyE/3vssOM3cDY8/s320/Crizotinib1.png" /></a></div><div class="separator" style="clear: both; text-align: center;"><br />
</div><b>Dacomitinib</b>&nbsp;aka PF-299,804 - Pfizer's EGFR, and HER2 inhibitor <br />
<pre>COc3cc2ncnc(Nc1ccc(F)c(Cl)c1)c2cc3NC(=O)C=CCN4CCCCC4</pre><br />
<div class="separator" style="clear: both; text-align: center;"><a href="http://3.bp.blogspot.com/_SlPG9DIz_AA/TCHwBaAeHFI/AAAAAAAAAyM/KVlDD46POEE/s1600/Dacomatinib1.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://3.bp.blogspot.com/_SlPG9DIz_AA/TCHwBaAeHFI/AAAAAAAAAyM/KVlDD46POEE/s320/Dacomatinib1.png" /></a></div><br />
<b>Orantinib</b>&nbsp;aka SU-6,668, Pfizer's Aurora, FGFR, VEGFR, and PDFGR inhibitor <br />
<pre>Cc3[nH]c(C=c1c(=O)[nH]c2ccccc12)c(C)c3CCC(=O)O</pre><br />
<div class="separator" style="clear: both; text-align: center;"><a href="http://1.bp.blogspot.com/_SlPG9DIz_AA/TCHwHknrKUI/AAAAAAAAAyU/wWFgYhZ4p2o/s1600/Orantinib1.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://1.bp.blogspot.com/_SlPG9DIz_AA/TCHwHknrKUI/AAAAAAAAAyU/wWFgYhZ4p2o/s320/Orantinib1.png" /></a></div><br />
<b>Ruxolitinib</b>&nbsp;aka INCB-18,424, Incyte's JAK2 inhibitor <br />
<pre>C#CC[C@H](C1CCCC1)n4cc(c2ncnc3[nH]ccc23)cn4</pre><br />
<div class="separator" style="clear: both; text-align: center;"><a href="http://3.bp.blogspot.com/_SlPG9DIz_AA/TCHwTA2_8YI/AAAAAAAAAyc/EF_GtfEVziw/s1600/Ruxolotinib1.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://3.bp.blogspot.com/_SlPG9DIz_AA/TCHwTA2_8YI/AAAAAAAAAyc/EF_GtfEVziw/s320/Ruxolotinib1.png" /></a></div><br />
<br />
<b>Silimitasertib</b>&nbsp;aka CX-4,945, Cylene's CK2 inhibitor <br />
<pre>O=C(O)c1ccc4c(c1)nc(Nc2cccc(Cl)c2)c3ccncc34</pre><br />
<div class="separator" style="clear: both; text-align: center;"><a href="http://3.bp.blogspot.com/_SlPG9DIz_AA/TCHwX3RsrKI/AAAAAAAAAyk/BLWSbxvu5FQ/s1600/Silmitasertib1.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://3.bp.blogspot.com/_SlPG9DIz_AA/TCHwX3RsrKI/AAAAAAAAAyk/BLWSbxvu5FQ/s320/Silmitasertib1.png" /></a></div><div class="separator" style="clear: both; text-align: center;"><br />
</div><b>Tivantinib</b>&nbsp;aka ARQ-197, Arqule's MET inhibitor <br />
<pre>O=C4NC(=O)[C@@H](c1cn3CCCc2cccc1c23)[C@@H]4c5c[nH]c6ccccc56</pre><div class="separator" style="clear: both; text-align: center;"><a href="http://2.bp.blogspot.com/_SlPG9DIz_AA/TCHwduFQqdI/AAAAAAAAAys/tLYYW6h_vF8/s1600/Tivantinib1.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://2.bp.blogspot.com/_SlPG9DIz_AA/TCHwduFQqdI/AAAAAAAAAys/tLYYW6h_vF8/s320/Tivantinib1.png" /></a></div>